Arthritic Therapeutic Global Market Report 2024

Description

Arthritic therapeutics are treatments aimed at relieving symptoms and improving the quality of life for individuals with arthritis. These therapies include medications, physical therapy, and other interventions designed to reduce pain, inflammation, and joint damage, helping to manage conditions such as osteoarthritis and rheumatoid arthritis.

Key drug classes used in arthritic therapeutics include tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, xanthine oxidase inhibitors, and others. TNF inhibitors work by blocking TNF, a protein involved in inflammation, to treat autoimmune diseases. They can be administered orally, parenterally, or topically and are used for various types of arthritis, including psoriatic arthritis, rheumatoid arthritis, osteoarthritis, and gout. These drugs are available through multiple distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

The arthritic therapeutic market research report is one of a series of new reports from The Business Research Company that provides arthritic therapeutic market statistics, including the arthritic therapeutic industry's global market size, regional shares, competitors with a arthritic therapeutic market share, detailed arthritic therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the arthritic therapeutic industry. This arthritic therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arthritic therapeutic market size has grown strongly in recent years. It will grow from $64.19 billion in 2023 to $68.10 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth observed in the historic period can be attributed to several factors, a rising number of diagnosed patients, greater awareness of symptoms, an increasing prevalence of obesity, enhanced diagnostic capabilities, and improved treatment outcomes.

The arthritic therapeutic market size is expected to see strong growth in the next few years. It will grow to $86.55 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The projected growth during the forecast period can be attributed to factors such as advancements in healthcare infrastructure, government initiatives, supportive regulatory frameworks, a focus on personalized medicine, and a shift toward patient-centric healthcare approaches. Key trends expected in this period include an emphasis on biosimilars, a move toward biologics, increased availability of biosimilars, a preference for the parenteral route, and the expansion of online pharmacies.

The rising incidence of arthritis is expected to drive the growth of the arthritic therapeutic market. Arthritis encompasses over 100 conditions primarily characterized by joint pain and inflammation. The increasing prevalence of arthritis is attributed to an aging population, rising obesity rates, and lifestyle factors that contribute to joint stress and inflammation. Treatments for arthritis help relieve symptoms, reduce inflammation, and improve joint function, thus enhancing the overall quality of life for those affected. For example, a June 2024 report from the Australian Institute of Health and Welfare, a government organization based in Australia, noted that approximately 514,000 people (2.0% of the population) were living with rheumatoid arthritis in 2022. Rheumatoid arthritis accounted for 2.0% of the total disease burden and represented 16% of the total burden for all musculoskeletal conditions in 2023. Thus, the growing incidence of arthritis is fueling the expansion of the arthritic therapeutic market.

Leading companies in the arthritis therapeutic market are concentrating on developing advanced solutions, such as biosimilar monoclonal antibody-based therapies, to improve treatment efficacy and reduce costs. These therapies are designed to closely replicate the effectiveness of original monoclonal antibodies, offering similar therapeutic benefits at potentially lower costs. For instance, in May 2024, Bio-Thera Solutions Ltd., a biopharmaceutical company based in China, introduced TOFIDENCE, an intravenous biosimilar monoclonal antibody formulation based on ACTEMRA. TOFIDENCE (tocilizumab-bavi) is developed as a biosimilar to the reference drug ACTEMRA and is approved for treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

In October 2023, Amgen Inc., a biotechnology company based in the US, acquired Horizon Therapeutics Plc for $27.8 billion. This acquisition aims to strengthen Amgen's portfolio of innovative medicines for rare diseases, leveraging Horizon Therapeutics' capabilities to reach more patients globally and drive long-term growth. Horizon Therapeutics plc is an Ireland-based biotechnology company specializing in arthritic therapies.

Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

North America was the largest region in the arthritic therapeutic market in 2023. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the arthritic therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arthritic therapeutics market consists of revenues earned by entities by providing services such as physical therapy services, occupational therapy, diagnostic services, and wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The arthritic therapeutics market also includes sales of analgesics, joint injections, supplements, and disease-modifying antirheumatic drugs (DMARDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arthritic Therapeutic Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arthritic therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arthritic therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arthritic therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Xanthine Oxidase Inhibitors; Other Drug Classes
2) By Route Of Administration: Oral; Parenteral; Topical
3) By Type: Psoriatic Arthritis; Rheumatoid Arthritis; Osteoarthritis; Gout; Other Types
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Hoffmann-La Roche Ltd; Merck & Co Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20452

1. Executive Summary

2. Arthritic Therapeutic Market Characteristics

3. Arthritic Therapeutic Market Trends And Strategies

4. Arthritic Therapeutic Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Arthritic Therapeutic Market Size and Growth

5.1. Global Arthritic Therapeutic Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Arthritic Therapeutic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Arthritic Therapeutic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Arthritic Therapeutic Market Segmentation

6.1. Global Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tumor Necrosis Factor (TNF) Inhibitors
Interleukin Inhibitors
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Xanthine Oxidase Inhibitors
Other Drug Classes
6.2. Global Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Topical
6.3. Global Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Psoriatic Arthritis
Rheumatoid Arthritis
Osteoarthritis
Gout
Other Types
6.4. Global Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Arthritic Therapeutic Market Regional And Country Analysis

7.1. Global Arthritic Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Arthritic Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Arthritic Therapeutic Market

8.1. Asia-Pacific Arthritic Therapeutic Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Arthritic Therapeutic Market

9.1. China Arthritic Therapeutic Market Overview
9.2. China Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Arthritic Therapeutic Market

10.1. India Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Arthritic Therapeutic Market

11.1. Japan Arthritic Therapeutic Market Overview
11.2. Japan Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Arthritic Therapeutic Market

12.1. Australia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Arthritic Therapeutic Market

13.1. Indonesia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Arthritic Therapeutic Market

14.1. South Korea Arthritic Therapeutic Market Overview
14.2. South Korea Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Arthritic Therapeutic Market

15.1. Western Europe Arthritic Therapeutic Market Overview
15.2. Western Europe Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Arthritic Therapeutic Market

16.1. UK Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Arthritic Therapeutic Market

17.1. Germany Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Arthritic Therapeutic Market

18.1. France Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Arthritic Therapeutic Market

19.1. Italy Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Arthritic Therapeutic Market

20.1. Spain Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Arthritic Therapeutic Market

21.1. Eastern Europe Arthritic Therapeutic Market Overview
21.2. Eastern Europe Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Arthritic Therapeutic Market

22.1. Russia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Arthritic Therapeutic Market

23.1. North America Arthritic Therapeutic Market Overview
23.2. North America Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Arthritic Therapeutic Market

24.1. USA Arthritic Therapeutic Market Overview
24.2. USA Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Arthritic Therapeutic Market

25.1. Canada Arthritic Therapeutic Market Overview
25.2. Canada Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Arthritic Therapeutic Market

26.1. South America Arthritic Therapeutic Market Overview
26.2. South America Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Arthritic Therapeutic Market

27.1. Brazil Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Arthritic Therapeutic Market

28.1. Middle East Arthritic Therapeutic Market Overview
28.2. Middle East Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Arthritic Therapeutic Market

29.1. Africa Arthritic Therapeutic Market Overview
29.2. Africa Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Arthritic Therapeutic Market Competitive Landscape And Company Profiles

30.1. Arthritic Therapeutic Market Competitive Landscape
30.2. Arthritic Therapeutic Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Hoffmann-La Roche Ltd
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Arthritic Therapeutic Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca Pharma AB
31.4. GlaxoSmithKline plc
31.5. Eli Lilly and Company
31.6. Amgen Inc.
31.7. Gilead Sciences Inc.
31.8. Regeneron Pharmaceuticals Inc.
31.9. Astellas Pharma Inc.
31.10. Biogen Inc.
31.11. Vertex Pharmaceuticals Incorporated
31.12. Zimmer Biomet Holdings Inc.
31.13. UCB Pharma S.A.
31.14. Incyte Corporation
31.15. Celltrion Inc.

32. Global Arthritic Therapeutic Market Competitive Benchmarking

33. Global Arthritic Therapeutic Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Arthritic Therapeutic Market

35. Arthritic Therapeutic Market Future Outlook and Potential Analysis

35.1 Arthritic Therapeutic Market In 2028 - Countries Offering Most New Opportunities
35.2 Arthritic Therapeutic Market In 2028 - Segments Offering Most New Opportunities
35.3 Arthritic Therapeutic Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer